FRMM - 180 Life Sciences Corp.

3
-0.290   -9.667%

Share volume: 386,156
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$3.29
-0.29
-0.09%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 31%
Liquidity 0%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-13.29%
1 Month
-13.29%
3 Months
-71.96%
6 Months
22.95%
1 Year
150.00%
2 Year
-18.92%
Key data
Stock price
$3.00
P/E Ratio 
0.00
DAY RANGE
$2.91 - $3.36
EPS 
-$1.81
52 WEEK RANGE
$0.66 - $24.44
52 WEEK CHANGE
$154.24
MARKET CAP 
299.268 M
YIELD 
N/A
SHARES OUTSTANDING 
21.399 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
1.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$505,804
AVERAGE 30 VOLUME 
$598,665
Company detail
CEO: Jim N. Woody
Region: US
Website: 180lifesciences.com
Employees: 7
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

1180 Life Sciences Corp. develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Recent news